Hematologic Malignancy Requiring An Allogeneic Hematopoietic Stem Cell Transplant Without Donor
📧 Sign up to get email alerts when something new happens for Hematologic Malignancy Requiring An Allogeneic Hematopoietic Stem Cell Transplant Without Donor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe. [Phase 1, Phase 2]
A Phase 1/2 clinical trial is testing an improved dose of UM171 to enhance the effectiveness and safety of cord blood transplantation; recru…